Thyroid dysfunction is common among IgAN patients and is associated with more severe clinical and pathological features, such as increased proteinuria and advanced CKD stages. These findings underscore the importance of monitoring thyroid function and implementing targeted interventions to improve outcomes in IgA nephropathy patients.